ORION: Inclisiran Phase 3 Trials Published ORION: Inclisiran Phase 3 Trials Published

Three phase 3 trials of the novel RNA agent have been published, all showing an approximate halving of LDL cholesterol levels with the drug, which is given just twice a year by subcutaneous injection.Medscape Medical News
Source: Medscape Cardiology Headlines - Category: Cardiology Tags: Neurology & Neurosurgery News Source Type: news